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The renal uptake of proteins: A nonselective process in conscious rats.
The selectivity of the renal reabsorption of proteins has been investi-
gated by competition experiments in conscious rats. The animals were
intravenously injected with increasing doses of proteins over a wide
range of net charge and size, including lysozyme, cytochrome C,
metallothionein, /32-microglobulin, retinol-binding protein, albumin and
IgG. The urinary excretion of exogenous proteins injected concomi-
tantly (human 132-microglobulin, retinol-binding protein, albumin and/or
egg white lysozyme depending on the experiment) and of rat 132-
microglobulin, albumin and IgG was determined with specific im-
munoassays. The results show that low molecular weight cationic
proteins and low or high molecular weight anionic proteins can increase
each other's urinary excretion. Several observations strongly suggest
that these effects result from a competitive inhibition of renal uptake.
The phenomenon is dose-related in most cases and, as evidenced by
cytochrome C injection, transient, reproducible and saturable. In
addition, the injected proteins induce a tubular type proteinuria irre-
spective of their net charge and size. In the case of cationic proteins,
this finding excludes the possibility of an enhanced glomerular perme-
ability due to a partial neutralization of the glomerular polyanion which,
as demonstrated with protamine sulfate, entails a glomerular type
proteinuria. These quantitative data on the mutual inhibition of renal
uptake of a wide spectrum of specific proteins lead us to challenge the
concept of charge- and size-selective tubular reabsorption of proteins,
and to postulate that proteins filtered through the glomeruli are taken up
by common tubular endocytotic sites irrespectively of their physico-
chemical features. As demonstrated by the ability of /32-microglobulin
and IgG to inhibit the uptake of lysozyme, the affinity of a protein for
reabsorption sites is not simply related to its size and net positive
charge. Evidence is also presented that proteins, when administered
intravenously at high doses, induce a lysosomal enzymuria most likely
reflecting a stimulated exocytosis.
The ability of renal tubular epithelium, particularly of proxi-
mal tubular cells, to reabsorb proteins has been known for a
long time [1, 2]. Morphological studies, performed mainly in the
sixties, have demonstrated that proteins are reabsorbed by
segregation into endocytotic vesicles at the apical border of
tubular cells. These vesicles then migrate to the interior of the
cell where they eventually fuse with lysosomes within which
proteins are digested. This process of renal tubular uptake and
degradation of proteins has been initially described for large
proteins (albumin, hemoglobin, horseradish peroxydase, fer-
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ritin) and later for small proteins such as lysozyme, growth
hormone or insulin [3—51. There is convincing evidence that the
endocytosis of proteins by tubular cells is, like for other cell
types, of the adsorptive type, that is, that filtered proteins bind
to the luminal membranes before segregation into endocytotic
vesicles [61. Several studies suggest that this binding occurs
between cationic groups of protein molecules and anionic sites
of the tubular cells membrane [7—11].
The question of the selectivity of the process of renal uptake
of proteins remains unresolved. Initially, the tubular reabsorp-
tion of proteins has been assumed to be nonselective. This view
was mainly based on the observation made by Hardwicke and
Squire [121 in the fifties that the intravenous infusion of albumin
in nephrotic patients produces an increase in the clearance of
globulins proportional to the albumin clearance. This nonselec-
tive hypothesis has been challenged by a number of authors
arguing that the occurrence of tubular or glomerular type
proteinuria in patients with primarily tubular or glomerular
dysfunction can be explained only by postulating the existence
of two different mechanisms for the reabsorption of low and
high molecular weight proteins [13—17]. This interpretation is
supported by experimental studies reporting the lack of in-
crease of albuminuria in rats receiving high loads of f32-micro-
globulin [18] or lysozyme [19] and also by the fact that the
tubular uptake of low molecular weight proteins is more effi-
cient than that of high molecular weight proteins [20, 21].
Another mode of selectivity which has been postulated is the
charge selectivity. Indeed, if the existence of a competition
between proteins of the same charge such cytochrome C and
lysozyme is well documented in the literature [7, 22—24], by
contrast, several studies have failed to conclusively demon-
strate a competition between anionic and cationic proteins for
the reabsorption process [6, 22, 25]. To explain this lack of
competition between anionic and cationic proteins, Sumpio and
Maack [22] have proposed the selective constraint model in
which cationic proteins can compete with each other without
interfering with the reabsorption of anionic proteins.
Recently, we have reported that /32-microglobulin and albu-
min can inhibit each other's tubular reabsorption in rat [26].
This observation led us to question the size selectivity of the
renal uptake of proteins and to postulate the existence of a
common transport system for both low and high molecular
weight proteins. In the present study sensitive immunoassays
have been used to investigate all the possible interactions at the
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Species
Protein
abbre-
viation
Molecular
weight
Iso-
electric
point
Rat
metallothionein Mt 6,600 4.35
132-microglobulin (32-m 11,700 6.6—7.2
lysozyme Lys 14,600 11
a2-U globulin a2-U 18,600 4.6
albumin Aib 64,600 4.7
immoglobulin G IgG 160,000 6.9—7.2
/3-N-acetyl-D-gtucosaminidase NAG 180,000
f3-galactosidase /3-gal 80,000
Human
-microglobulin J32-m 11,800 5.4; 5.7
retinol-binding protein RBP 21,400 4.4—4.8
albumin Aib 66,300 4.9
Chicken
egg white lysozyme Lys 14,600 >10
egg albumin AIb 45,000
Horse
heart cytochrome C Cyt C 12,400 10
myoglobin 16,900 7
Bovine
albumin AIb 66,200 4.5
Rabbit
immunoglobulin G IgG 160,000 6.9—7.2
Herring
protamine sulfate 5,000—10,000
tubular level between main representatives of the low and high
molecular weight protein classes.
The results obtained indicate that proteins can compete for
tubular uptake whatever their size and net charge, and provide
thus a strong experimental support in favor of the nonselective
reabsorption hypothesis formulated by Hardwicke and Squire
more than thirty years ago.
Methods
Proteins
The characteristics of the 18 proteins used in the present
study are presented in Table 1. The source and degree of purity
of proteins which were injected to rats and/or used as standards
are given below. Albumin from human serum or from bovine
serum (Fraction V, purity 96 to 99%), cytochrome C (type III,
from horse heart, purity 95 to 100%), lysozyme (from chicken
egg white, grade I) and protamine sulfate (from Herring, grade
III, essentially histone free) were purchased from Sigma Chem-
ical Co. (St. Louis, Missouri, USA). Egg white albumin (oval-
bumin ca 70% and conalburnin ca 18%) and equine myoglobin
(research grade, purity > 95%) were from Serva Feinbiochem-
ica (D-6900 Heidelberg, FRG). Human /32-microglobulin and
retinol-binding protein were purified from the urine of a patient
with tubular proteinuria as described previously and their purity
was demonstrated by electrophoresis and immunoelectrophore-
sis [27]. Metallothionein was purified from the liver of rats
treated with cadmium (1 mg Cd/kg, i.p. 5 times a week for 2
months) by the method of Bflhler and Kägi [281. The solution
injected to rats contained both forms of metallothionein (Mt I
and Mt II). Rabbit IgO was purified by ammonium sulfate
precipitation (50% of saturation) [29]. Rat /32-microglobulin
(/32-m) and cr2-globulin were purified as described respectively
by Viau, Bernard and Lauwerys [30] and Vandoren et a) [31]
with preparative isoelectric focusing as final purification step.
Experimental protocol
Experiments were performed in female Sprague-Dawley rats
weighing 150 to 200 g. The animals were lightly anesthetized
with ether and injected in the tail vein (0.5 or 1 ml/100 g) with a
0.9% sodium chloride solution containing increasing concentra-
tions of an exogenous protein together with a small and con-
stant amount of one or a few other exogenous proteins (human
/32-m and RBP, egg lysozyme: 0.125 mg/kg; human albumin: 5
mg/kg).
Immediately after the injection, the animals were placed in
individual metabolism cages equipped with urine/feces separa-
tors. Urine was collected for a period of two hours, which is
sufficient to get a volume of I to 2 ml. Complete voiding before
and after urine collection was ensured by a pressure on the
bladder. This experimental protocol was used to challenge the
rats with a total of 10 different proteins. Table 2 gives the range
of doses at which these proteins were injected and lists the
various specific proteins which were subsequently measured in
rat urine. In some experiments, the glomerular filtration rate
(GFR) was measured by the 51Cr-EDTA method according to
Provoost et al [32].
Analytical methods
Eight different proteins were measured in rat urine by means
of specific and sensitive latex agglutination tests [33]: rat IgG,
albumin, cr2-u globulin and /32-microglobulin; human albumin,
retinol-binding protein and -microg1obulin, and egg white
lysozyme. Antibodies against the human proteins were ob-
tained from Dakopatts (Copenhagen F, Denmark) whereas the
antibodies against rat IgG and albumin were from USB (Cleve-
land, Ohio, USA). The antibodies against rat f3-microglobulin,
rat a2-u globulin and egg white lysozyme were produced in our
Table 1. Proteins characteristics
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Fig. 1. Effects in rat of increasing intravenous doses of human /32-rn on
the urinary excretion of two exogenous proteins injected concomitantly
(egg Lys and human RBP, 0.125 mg/kg) and of endogenous fi2-m, Aib,
IgG and NAG. * P < 0.05. Abbreviations are in Table I.
0.01 0.04 0.17 0.34 0.68 1.36
pinoukg
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Table 2. Protocol of the competition experiments
.Protein
injected
Dose
mg/kg
Proteins measured in rat urineb
Rat Humane Eggc
NAG fl-gal /32-m Lys s2-U Aib IgG f32-m RBP Aib Lys
Human th-m
Human RBP
0.125—4
8
16
4—16
0.156—10
*
*
*
*
* *
*
*
*
* *
*
*
*
*
*
*
*
*
* *
*
Bovine AIb 125—1,000 * * * * * * *
Rabbit IgG 250—2,000 * * * *
EggLys 0.156—160 * * * * * * *
Horse Cyt C
Protamine
0.625—160
100
50—400
0—40
*
*
*
*
*
*
*
* * *
*
*
*
*
*
* * *
sulfate
Rat Mt 1.2, 2.4 4'
Horse Myo- 20—160 *
globin
Egg Alb 100-400 4'
a Single intravenous injection except for protamine sulfate which was administered twice at a dose of 20 mg/kg at 1 hour interval.b The proteins which have been measured in rat urine are indicated by an asterisk.
Injected concomitantly at a fixed dose of 0.125 mg/kg (human /32-m and RBP, and Egg Lys) or 5 mg/kg (human Alb).
Dose of human RBP, mg/kg
Fig. 2. Effects in rat of increasing intravenous doses of human RBP on
the urinary output of two human proteins administered concomitantly
(132-rn, 0.125 mg/kg and Aib, 5 mg/kg and of six endogenous proteins
(132-m, Aib, NAG, Lys, a2-U and IgG). * P<0.05. Abbreviations are in
Table 1.
laboratory according to the procedure described by Viau et al
[30]. These immunoassays were calibrated either with a pool of
normal sera (rat IgG and albumin) or with purified proteins. The
limit of detection of these immunoassays (defined as the protein
concentration agglutinating 10% of the latex particles) varies
from 0.5 tWliter for small proteins like /32-microglobulin up to 5
p.glliter for larger proteins such as IgG. But as urines must be
diluted at least fivefold to avoid interferences, the lowest
protein concentration accurately measurable with these im-
munoassays ranges from 2.5 to 25 pg/liter. The antibodies
directed against albumin or f32-microglobulin of human or rat
origin did not cross react with rat or human protein at concen-
trations which were observed in rat urine. For rat IgG, it was
0.125 0.25 0.5
Dose of bovine serum albumin, g/kg
Fig. 3. Effects in rat of increasing intravenous doses of bovine serum
Alb on the urinary excretion of three exogenous proteins administered
concomitantly at the dose of 0.125 mg/kg (human f32-rn and RBP and
egg Lys) and of endogenous 132-rn, IgG, NAG and Aib. * P < 0.05.
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0.25 0.5 1 2
Dose of rabbit IgG, glkg
Fig. 4. Effects in rat of increasing intravenous doses of rabbit JgG on
the urinary excretion of egg Lys (administered concomitantly 0.125
mg/kg) and of rat j32-m, A/b and IgG. * P < 0.05.
ascertained by chromatography of urine samples on Sephadex
G-200 that the method detected only the intact protein (Mr
around 160,000) and not immunologically active fragments.
The urinary activities of fi-N-acetyl-D-glucosaminidase and
/3-galactosidase were measured by the fluorimetric assay of
Tucker et al [34] and that of lactate dehydrogenase and alkaline
phosphatase by previously described photometric methods
[35]. Alanine aminopeptidase and lysozyme (in rats not injected
with egg white lysozyme) were assayed by the methods of Jung
and Scholz [36] and Prockop and Davidson [37], respectively.
Calculations and statistics
The urinary excretion of proteins was expressed in ng or jig
per hour. The results were analyzed by one-way analysis of
variance followed by Dunett's multiple comparison test with P
<0.05 considered as significant [38]. For most urinary param-
eters the statistical analysis was performed on log-transformed
data. Because of the impossibility to represent on the same
graph all urinary parameters in absolute values, the results have
been presented in Figures 1 to 6 in terms of relative urinary
excretion, that is, as the ratio between the mean urinary
excretion in protein-injected rats and that observed in controls,
each value being the mean of four animals.
Results
Injection of anionic proteins
1. Human J32-micro globulin. Four experiments were per-
formed to study the effect of human firm on urinary protein
excretion. The doses at which firm was administered and the
specific urinary proteins measured in these experiments are
indicated in Table 2.
The results, summarized in Figure 1, show that human firm
caused a dose-related increase in the urinary excretion of rat
fi2-m and of egg white lysozyme. The excretion of human RBP
and rat albumin and IgG were also significantly increased, but
the dose-effect relationships quickly leveled off. It is interesting
to note that the urinary excretion of the injected human firm
increased and became linearly related to the administered dose
when the latter exceeded 0.5 mg/kg. The fact that the excretion
of urinary proteins started to increase precisely from that dose
was highly suggestive of a competition between J3-m and other
proteins for renal uptake. The firm injection caused no change
in the diuresis. For instance, the urinary flow averaged 0.76
0.55 (sD) ml/hr in rats given 16 mg/kg of th-m against 0.88 0.25
(SD) mI/hr in controls (N = 4 in both groups).
2. Human retinol-binding protein. When injected to rats at
doses between 0.156 and 10 mg/kg, human RBP enhanced in a
dose-related manner the urinary excretion of human firm
C0
a,
ax
a,
CDC
a,>
CD
a,
100
10
0.5
500
100
10
Lys (Egg)
P2-rn
C0
Aib
IgG
CDC
a,>
CD
a,
(Hu)
RBP (Hu)
Aib
1.56 6.253.13 12.5
p.mo//kg
B
,Atb(Hu)
NAG
IgG
0.5
0.011 0.043 0.17 0.68 2.74 11
p.mo//kg
0.156 0.625 2.5 10 40 160
Dose of egg lysozyme, mg/kg
Fig. S. Effects in rat of increasing intravenous doses of egg Lys on the
urinary output of human /32-m, RBP and AIb (injected concomitantly at
the dose 0.125, 0.125 and 5 mg/kg, respectively) and of rat firm, A/b,
NAG and lgG. * P < 0.05.
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Fig. 6. Effects in rat of increasing intravenous doses of cyt C on the
urinary excretion of human /32-m, RBP and AIb (injected concomitantly
at the dose of 0.125, 0.125 and 5 mg/kg, respectively) and of rat /32-m,
Lys, a2-U, Aib, NAG, /3-gal and IgG. * P < 0.05.
injected simultaneously at the dose of 0.125 mg/kg (Fig. 2). At
the highest dose, human RBP also caused a slight increase in
the urinary output of rat /32-m. No change was observed in the
excretion of the six other urinary proteins which were mea-
sured. Diuresis was also unaltered in this experiment (results
not shown). At comparable doses expressed in mg or in smol,
the effects of human RBP on urinary proteins was much less
pronounced than those observed with human /32-m. A possible
explanation for this lower ability of human RBP to increase
protein excretion could be that the glomerular filtration of RBP
is lower than that of /32-m, as suggested by the amounts of
protein recovered in rat urine (Figs. I and 2).
3. Bovine serum albumin. At the doses of 0.25, 0.5 and 1 g/kg,
bovine serum albumin produced a dose-dependent rise in the
urinary excretion of human and rat /32-m, egg white lysozyme
and rat IgG (Fig. 3). At the highest dose, bovine serum albumin
also enhanced the excretion of NAG, rat albumin and human
RBP. The injection of bovine serum albumin increased the
urinary flow from a mean value of 0.76 (SD: 0.25) mI/hr in
controls up to 1.43 (SD: 0.57) mI/hr in rats challenged with
highest dose (P < 0.05). This effect was not accompanied by a
change in the GFR, which averaged 1.17 0.06 (SD) mLlmin x
100 g in rats given the 1 g/kg dose of bovine serum albumin
against 1.09 0.08 in controls (N = 4, P > 0.05).
4. Rabbit IgG. The injection to rats of rabbit IgG at doses
from 0.25 to 2 g/kg induced a dose-related increase of the
urinary excretion o:f rat f32-m and concomitantly injected, egg
white lysozyme. The albuminuria of rats given the highest dose
was also significantly increased. The treatment also induced a
progressive rise in the rat IgG excretion but without reaching
the level of statistical significance. The GFR and the urinary
flow of rats challenged with 2 g of rabbit IgG per kg showed no
significant change by comparison with that of controls: GFR
(mean SD, N = 4), 0.99 0.015 versus 1.02 0.104 mi/mm
x 100 g in controls and urinary flow, 0.64 0.38 versus 0.93
0.34 mt/hr in controls.
Injection of cation/c proteins
1. Lysozyme. The changes in urinary proteins caused by the
injection of lysozynie are shown in Figure 5. From the dose of
10 mg/kg, lysozyme increased in a dose-related fashion the
urinary excretion of anionic low molecular weight proteins, that
is rat /3,-rn, human /32-m and human RBP. At the dose of 160
mg/kg, lysozyme induced a significant rise of the urinary output
of rat albumin, human albumin and NAG. Urinary rat IgG was
affected only at the 40 mg/kg dose. The mean urinary flow
varied from 0.54 (SD: 0.15) in controls to 0.94 (SD: 0.33) mi/hr in
rats challenged with the highest dose of lysozyme (P > 0.05).
2. Cytochrome C. Among the proteins injected to rats,
cytochrome C produces the earliest and highest elevations of
urinary protein excretion (Fig. 6). A dose of cytochrome C as
low as 2.5 mg/kg increases the urinary excretion of rat and
human f32-m by a factor of 25 and 10, respectively. The urinary
excretion of rat lysozyme was significantly increased from the
dose of 0.625 mg/kg, but the effect became dose-related only
from the dose of 2.5 mg/kg. Cytochrome C also produced
dose-related increases in the urinary excretion of rat albumin
and human albumin (injected concomitantly). It is of interest to
note that the urinary excretion curves of the two low molecular
weight human proteins used as tracers leveled off from the
cytochrome C dose of 10 mg/kg. From that dose, the tubular
transport of these proteins was completely inhibited by cyto-
chrome C. On the basis of the relative increases in the urinary
excretion observed under these conditions, the fractional reab-
sorption of human /32-m and human RBP by the rat kidney was
estimated at about 99.9% and 87%, respectively. An interesting
observation made in this experiment was the marked increase
of the urinary activity of NAG and /3-galactosidase. As shown
in Table 3, the enhanced excretion of these two lysosomal
enzymes was not accompanied by an increase in the urinary
excretion of lactate dehydrogenase and the brush border en-
zymes, alanine aminopeptidase and alkaline phosphatase.
Two additional experiments were performed to get some
insight into the origin of this lysosomal enzymuria and the
mechanism by which cytochrome C increased the urinary
excretion of low and high molecular weight proteins. In a first
experiment, rats were given three intravenous injections of
cytochrome C (100 mg/kg) at four hour intervals, and their urine
was collected every two hours for measuring the excretion of
rat /32-m, 13-galactosidase and NAG. As shown in Figure 7, the
repeated intravenous injection of cytochrome C induced repro-
ducible urinary excretion peaks of /32-m. The injections of
2-m
Lys
Aib
"NAG
13-GAL
RBP (Hu)
Aib (Hu)
IgG
0.013 0.05 0.2 0.8 3.23 12.9
p.mol/kg
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Controls Cytochrome C
mU/hour
Alkaline phosphatase
Alanine aminopeptidase
Lactate dehydrogenase
/3-N-acetylglucosaminidase
/3-galactosidase
24 3.4
4.6 1.3
5.8 1.6
1.8 0.34
1.6 0.30
23 3.7
3.8 0.41
5.4 1,5
8.1 2.7a
5.4 1.0k'
a p < 0.05 Student's t-test.
CYTC CYTC CYTC
0 2 4 6 8 10 12
Time, hours
Fig. 7. Time course of the urinary excretion of f32-m (•), NAG (0), and
f3-galactosidase () in rats repeatedly injected by the i. v. route with cyt
C (160 mg/kg, time 2, 6 and 10 hr). Mean SE; N = 5 * Significantly
different from the preinjection values at P < 0.05.
cytochrome C also produced a peak in the urinary activity of
NAG and j3-galactosidase, but the height of these peaks de-
creased after each injection, which contrasted with the repro-
ducibility of f32-m peaks. Furthermore, while the urinary excre-
tion of f3-m measured after each peak was progressively
increasing, that of lysosomal enzymes on the contrary returned
to levels which at each time were lower than the preinjection
value. This experiment indicated that the urinary excretion of
1.32-m and lysosomal enzymes closely paralleled the kinetic of
elimination of cytochrome C. It also suggested that different
mechanisms were involved in the increased urinary excretion of
f3-m and lysosomal enzymes.
The second experiment was performed to study the effect of
high doses of cytochrome C on the urinary excretion of high
molecular proteins. As shown in Figure 8, increasing the dose
of cytochrome C from 50 to 400 mg/kg did not appreciably
enhance the excretion of rat albumin or rat IgG. The levelling of
the curves depicted in Figure 8 was suggestive, as in the case of
human /32-m and RBP (Fig. 6), of a complete inhibition of the
tubular reabsorption of rat albumin and rat IgG. As the maxi-
mum relative increases in the urinary excretion induced by
cytochrome C ranged from 7 to 10 for rat albumin and 2 to 3 for
rat IgG, it could be concluded that the fractional reabsorption of
i---- -
--f-- - ------
0
.
4
.
8 16 32
.unolIkg
0 50 100 200 400
rat albumin ranged from 85 to 90% and that of rat IgG between
50 and 70%.
The GFR measured in rats challenged with 160 mg/kg of
cytochrome C (mean SD: 1.14 0.066 mllmin X 100 g) was
not significantly different from that of controls (1.13 0.13, N
= 4 in each group). Cytochrome C caused little change in the
urinary flow. For instance, in the last experiment, in which the
highest doses of cytochrome C were administered, the mean
urinary flow varied from 0.57 0.038 in controls to 0.65 0.042
mi/hr in rats given 200 mg/kg of cytochrome C (P > 0.05).
3. Protamine sulfate. Protamine sulfate was used in order to
determine the extent that a neutralization of the glomerular
polyanion may be involved in the effect of cytochrome C on the
urinary excretion of anionic high molecular weight proteins.
Protamine sulfate is a strongly cationic protein which is known
to increase the glomerular permeability to anionic proteins such
as albumin by neutralizing anionic charges along the glomerular
basement membrane [39, 40]. Protamine sulfate was adminis-
tered to rats at the dose of 20 or 40 mg/kg as two intravenous
injections given at one hour intervals. Urine was collected
immediately after the first injection for a period of two hours.
As shown in Figure 9, the effects of protamine sulfate on the
urinary excretion of rat albumin and IgG are markedly different
from that of cytochrome C. Protamine sulfate does not affect
the f32-microglobulinuria but causes a biphasic increase in the
albumin and IgG excretion. It must be pointed out that the
animals injected with the dose of 10 mg/kg of protamine sulfate
were polyuric compared to those given the 20 or 40 mg/kg
doses.
Comparison of the relative affinities of proteins for tubular
reabsorption sites
Figure 10 compares the urinary excretion curves of rat f32-m
in rats challenged with increasing doses of various anionic or
cationic proteins. Since all available evidence (Discussion) indi-
cated that the tubular uptake of rat th-m was competitively
inhibited by the administered proteins, these curves permitted a
comparison of the relative affinity for tubular reabsorption sites
Table 3. Effect in rat of an intravenous dose of cytochrome C
(200 mg/kg) on the urinary excretion of five kidney-derived enzymes
(mean SE, N = 5)
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Fig. 8. Effects in rat of increasing intravenous doses of cyt C on the
urinary flow (0) and on the urinary output of rat Aib (•) and IgG (•).
Mean SE, N = 5. * P < 0.05.
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21
2
>. 2
Dose of protamine sulfate, mg/kg
Fig. 9. Effects of increasing doses of protamine sulfate, administered
to rats as two intravenous injections at one hour interval, on the urinary
flow (0) and the urinary excretion of rat Aib (•), IgG (h), and 132-rn
(A). Mean SE, N = 5, * P < 0.05.
of proteins with a similar size. Figure 10 clearly demonstrates
that the affinity of a protein for tubular sites was not simply
related to its net positive charge since the anionic protein
human f32-m was a more potent inhibitor of rat 132-m uptake than
lysozyme (isoelectric point> 10). This was confirmed by the
fact that human /32-m can inhibit the renal uptake of egg
lysozyme (Fig. 1). Rat metallothionein, which is highly anionic
(isoelectric point: 4.35), has about the same affinity for tubular
sites as lysozyme if one takes into account that the dose (in
xmol) of metallothionein (Mr: 6600) injected is about twice
higher and that this protein most likely has a glomerular
filtrability close to that of lysozyme, as suggested by its
behavior on gel filtration (elution volume corresponding to a
apparent molecular weight of 10,000). With respect to larger
proteins, their relative affinity for tubular sites cannot be
estimated since their glomerular sieving coefficient under the
conditions of the experiment is unknown. Nevertheless, Figure
10 shows that the dose required to inhibit rat 132-m reabsorption
increased with the molecular weight.
Discussion
Studies on the selectivity of the renal uptake of proteins are
hampered by several practical difficulties. Firstly, conclusive
competition experiments can be conducted only if sufficiently
large amounts of pure protein are available, a condition which is
difficult to fulfill with some proteins like /32-m. The measure-
ment of specific proteins in biological fluids is another obstacle.
Usually proteins are labelled with 1251. The labeling, however,
not only requires the purification of the protein but also
involves a chemical reaction which may alter its conformation
and hence its behavior in the kidney. Furthermore, the labelling
method usually permits the study of the interaction only be-
tween two proteins in a single experiment. The use of sensitive
immunoassays in the present study enabled us to simulta-
neously examine the inhibitory effect of the injected protein on
the tubular reabsorption of up to seven other proteins. In
addition, owing to the single injection method, these investiga-
tions could be made in conscious rats thus avoiding the modi-
fications of renal physiology associated with anesthesia, sur-
gery or isolation of the kidneys.
The experimental conditions of the present study, however,
did not permit us to calculate the fractional reabsorption of
proteins. The renal uptake has been estimated indirectly from
their relative urinary excretion. This approach is valid for small
proteins like f32-m or lysozyme which have a glomerular sieving
coefficient close to 1. An inhibition of tubular uptake is the only
mechanism which can account for their increased excretion
when the GFR is not markedly reduced. This mechanism is also
the only plausible one for the increased excretion of albumin
and IgG induced by injecting rats with anionic f32-m. When the
animals are challenged with lysozyme and cytochrome C,
however, the increased excretion of anionic large proteins such
as albumin caused by the polycations might well reflect an
enhanced glomerular filtration due to a partial neutralization of
the glomerular polyanion, since these cationic proteins have
been found to bind to the glomerular basement membrane [41,
421. Several observations, however, make this possibility un-
likely. The patterns of albuminuria and /32-microglobulinuria
induced by protamine sulfate—a polycation which strongly
binds to glomerular polyanion [39, 401—are completely different
from that observed with cytochrome C and lysozyme. The
average 132-mlalbumin ratio observed in rats administered 40
mg/kg of protamine sulfate (= 200) or of cytochrome C (= 1) are
characteristic of the proteinuria of glomerular and tubular
origin, respectively [15]. In addition, comparison of the inhibi-
tory effect of cytochrome C on the tubular uptake of proteins
with that of lysozyme indicates that the former is fourfold more
active than the latter for high molecular weight proteins as well
as for low molecular weight proteins, for which the glomerular
filtration is likely to be independent of electrical charges. This
more potent inhibitory effect of cytochrome C is in agreement
with the apparent affinity of this protein for the renal uptake
process, which is about two orders of magnitude higher than
that of lysozyme [221.
The changes in urinary protein excretion induced by injecting
rats with high doses of bovine albumin and rabbit IgG most
likely also originate from a decreased tubular uptake. The main
evidence in favor of this explanation is that the proteinuria
induced by injecting these high molecular weight proteins is of
tubular type like that observed in rats challenged with low
molecular weight proteins. This decrease of tubular uptake
cannot be ascribed to hemodynamic changes. In the case of
rabbit IgG, the phenomenon is not accompanied by significant
changes in urinary flow. The twofold increase in urinary flow
induced by bovine albumin is also observed with human albu-
min, which yet exhibits a considerably lower inhibitory effect
on protein reabsorption. Furthermore, the average GFR deter-
mined during the first hour after the injection of albumin and
IgO did not show substantial modification. Even assuming the
possibility of acute transient hemodynamic changes which
would only have been detected by measuring the GFR over
shorter periods, these changes would be expected to be asso-
ciated with a glomerular rather than a tubular proteinuria.
It is interesting to point out that human serum albumin, which
has almost the same size and electrophoretic mobility (tested at
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pH 6.5 on agarose gel as bovine serum albumin, induces
practically no increase in the urinary excretion of low or high
molecular weight proteins. For instance, at the 1 g/kg dose,
human serum albumin produces only a two-fold increase in the
urinary excretion of rat th-m against an elevenfold increase in
the case of bovine serum albumin [26]. As discussed previously
[26], this difference, which most likely results from a very low
affinity of human albumin for tubular binding sites, explains the
lack of substantial increase in the urinary output of low molec-
ular weight proteins in patients with primarily glomerular dis-
eases.
The explanation for the induction of a tubular proteinuria in
protein-challenged rats lies in the efficiency of the reabsorption
process. The renal reabsorption rates of proteins can be esti-
mated from the relative increases in urinary excretion following
saturating loads of cytochrome C (Fig. 6): human th-m 99.9%;
human RBP 97%; rat th-m > 99.7%; rat lysozyme > 99%; rat
albumin 85 to 90%; and rat IgG 50 to 70%. The reabsorption
rates of rat and human f32-m are very close to those we have
previously derived from the relative clearance of rat /32-m
(99.97%) [30] and from the recovery in urine of human th-m
administered at low doses to rats (99.7%) [43]. Our estimate of
the reabsorption rate of albumin agrees well with the values
reported in the literature, which oscillate around 90% [21, 44,
451. These data suggest that for the primary low and high
molecular weight plasma proteins, the efficiency of the tubular
reabsorption is inversely related to the size of the protein,
which thus explains the higher relative increase in the urinary
excretion of low molecular weight proteins in case of an
inhibition of tubular reabsorption.
The inhibition of protein reabsorption observed in the exper-
iments reported here presents several features which are highly
suggestive of a competition process. The inhibitory effect is in
most cases dose-related, saturable and, as shown in the exper-
iment with human /32-m, starts precisely when the reabsorption
capacity for the injected protein is exceeded. The experiment
realized with cytochrome C also shows that the inhibitory effect
is a reproducible phenomenon which closely parallels the
elimination of the injected protein.
As summarized in Figure 11, the present study shows that
proteins, whatever their size and charge can compete with each
other for renal uptake. The tubular uptake of anionic proteins
such as firm and albumin can be completely inhibited by
cytochrome C and lysozyme. The urinary excretion of rab firm
is already increased by a factor of 25 following the injection of
only 2.5 mg/kg of cytochrome C, a dose giving a peak serum
concentration around 25 mg/liter. This contrasts with the study
of Sumpio and Maack [22] which failed to evidence a competi-
tion between cytochrome C and human firm in isolated rat
kidney perfused with up to 250 mg/liter of cytochrome C. The
existence of common reabsorption sites for cationic and anionic
proteins is corroborated by the ability of human fl-m to inhibit
the renal uptake of egg lysozyme. Our results also clearly show
that low and high molecular weight protein can compete with
each other for tubular uptake. They thus agree with the early
observations of Hardwicke and Squire [12] on the albumin-
globulin competition and also with the more recent finding of
Foulkes [24] that hemoglobin inhibits the tubular uptake of
metallothionein. But the most convincing evidence that the
renal uptake of proteins is a nonselective process involving
common reabsorption sites comes from the mutual inhibition
between the cationic low molecular weight protein, lysozyme
and the anionic high molecular weight proteins, albumin and
IgG. (Fig. 11).
The proposal by Sumpio and Maack [22] of the selective
constraint model accounting for the lack of competition be-
tween anionic and cationic proteins and for a facilitated access
of cationic proteins to the endocytotic sites is therefore not
supported by our data. The concepts of binding, access and site
selectivity (that is, preferential reabsorption site for th-m)
developed by these authors are also not supported by the
present study, which on the contrary suggests the existence of
Lys (Egg)
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a common reabsorption mechanism for which proteins present
different affinities. The factors which determine the affinity of
proteins for tubular reabsorption sites are poorly understood.
As already unveiled by previous works [9—11, 20], the net
positive charge and molecular size of the protein are not the
only determinants of this affinity. The fact that the apparent
affinity for tubular sites of human /32-m is higher than that of
lysozyme confirms that other molecular features of the pro-
teins, such as the nature and the distribution of the charges,
must contribute importantly to their affinity for the membranes
of tubular cells.
In a recent study on the kinetics of albumin uptake by
isolated tubule, Park and Maack [471 have postulated the
existence of two systems for the reabsorption of albumin: a low
capacity system mediated by adsorptive endocytosis and a high
capacity system that Park and Maack [47] ascribe to fluid
endocytosis. At low albumin concentrations in tubular fluid,
adsorptive endocytosis would account for the bulk of albumin
uptake, while at high tubular fluid concentrations fluid endocy-
tosis would be responsible for most of the uptake capacity. A
dual kinetic has also been observed for the uptake of metal-
lothionein [48] which suggests that this phenomenon might
apply to all proteins. However, the possibility remains that this
dual kinetic merely reflects the existence of two different
binding sites on the brush border membrane. This hypothesis
has been suggested by Rabkin, Petersen and Mamlock [49] who
identified two different binding sites for insulin on the tubular
brush border, one with a high affinity and a low capacity and the
other with opposite characteristics. Since by definition compe-
tition between various substances implies their binding to
common sites or receptors, the fact that cationic substances
such as cytochrome C in the present study or lysine in the study
by Mogensen and Solling [8] can completely inhibit the renal
uptake of albumin and other proteins measured in urine, sug-
gests that protein uptake occurs mainly via adsorptive endocy-
tosis. This conclusion is also consistent with the inability of
tubule to reabsorb neutral polymers such as dextrans or poly-
vinylpyrrolidone [8].
A striking observation made in the present study is the
lysosomal enzymuria induced by high doses of cytochrome C,
lysozyme or bovine serum albumin. Because of their high
molecular weight, NAG and 13-galactosidase can derive only
from renal epithelial cells. The possibility of exfoliation of
damaged tubular cells is excluded by the lack of increase in the
urinary excretion of lactate dehydrogenase and of the brush
border enzymes, alanine aminopeptidase and alkaline phospha-
tase. This lysosomal enzymuria most likely results from a
stimulation of the exocytosis. This is indeed the only mecha-
nism which can explain the fact that in rats repeatedly injected
with cytochrome C, both the baseline and peak excretion of
lysosomal enzymes progressively decrease while the 2-m
excretion shows reproducible peaks with increasing preinjec-
tion values (Fig. 7). This explanation is also consistent with data
from the literature demonstrating that rat kidney releases ap-
proximately 20% of its NAG activity per day by exocytosis [50]
and that in mice this process can be activated by the adminis-
tration of testosterone [51].
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